A Natural Cysteine Variant Reveals Disulfide-Dependent Structural and Functional Heterogeneity of Factor XI

Background: Factor XI (FXI) is a coagulation protease that contributes to thrombin amplification. FXI circulates as a disulfide-linked homodimer whose structure and function depend on a complex cysteine network comprising 17 intrachain disulfide bonds, free Cys29, and the interchain Cys339-Cys339 disulfide bond. Objectives: . Methods: Clinical, biochemical, genetic, and functional studies were performed in the proband and relatives. Thrombin generation was triggered with tissue factor and silica. Recombinant wild-type (WT) and mutant FXI were expressed in HEK293 cells and evaluated by immunoblotting, functional assays, and mutagenesis, including liquid chromatography-electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS) under non-reducing thiol-alkylating conditions. Results: The proband showed a mild prekallikrein deficiency and severe FXI deficiency with residual procoagulant FXI (FXI:C) activity (7%) and two disulfide-linked FXI species with different electrophoretic mobilities in plasma, which collapsed into a single entity under reducing conditions. Recombinant expression reproduced this heterogeneity in dimeric and apparent monomeric species. Mutagenesis did not support Cys295-mediated interchain disulfide formation or involvement of Cys29 in the aberrant dimer. Proteomic analysis discarded interaction with other proteins and identified Carbamidomethylation (CAM)-modified Cys317, Cys321, and Cys193 exclusively in mutant FXI, indicating altered thiol availability. Contact pathway-dependent FIX activation in the proband was associated with impaired thrombin generation, whereas tissue factor-triggered thrombin generation was preserved. The proband had no spontaneous bleeding and underwent two procedures uneventfully with prophylaxis. Conclusion: The p.Phe295Cys variant is associated with disulfide-dependent structural heterogeneity and impaired FXI function. The findings support perturbation of the native FXI disulfide network but do not establish the precise alternative disulfide connectivity.

Authors

Institutions

Publication Details

Journal
Thrombosis and Haemostasis
Published
2026-11-06
DOI
https://doi.org/10.1055/a-2985-8556
Primary Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Natural Cysteine Variant Reveals Disulfide-Dependent Structural and Functional Heterogeneity of Factor XI

Belén de la Morena‐Barrio, Javier Corral, Carlos Bravo‐Pérez, Francisco José López‐Jaime et al.
1 links
Thrombosis and Haemostasis
Coagulation, Bradykinin, Polyphosphates, and Angioedema
article

A Natural Cysteine Variant Reveals Disulfide-Dependent Structural and Functional Heterogeneity of Factor XI

Belén de la Morena‐Barrio, Javier Corral, Carlos Bravo‐Pérez, Francisco José López‐Jaime, Esther Navarro, María Eugenia de la Morena‐Barrio, Antonia Miñano, Marı́a Luisa Lozano, José Padilla, Vicente Vicente, David Zaragoza-Huesca, Juan José Rojo-Carrillo, Maria Consuelo Arques, Maria Pacheco
article en

Abstract

Background: Factor XI (FXI) is a coagulation protease that contributes to thrombin amplification. FXI circulates as a disulfide-linked homodimer whose structure and function depend on a complex cysteine network comprising 17 intrachain disulfide bonds, free Cys29, and the interchain Cys339-Cys339 disulfide bond. Objectives: . Methods: Clinical, biochemical, genetic, and functional studies were performed in the proband and relatives. Thrombin generation was triggered with tissue factor and silica. Recombinant wild-type (WT) and mutant FXI were expressed in HEK293 cells and evaluated by immunoblotting, functional assays, and mutagenesis, including liquid chromatography-electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS) under non-reducing thiol-alkylating conditions. Results: The proband showed a mild prekallikrein deficiency and severe FXI deficiency with residual procoagulant FXI (FXI:C) activity (7%) and two disulfide-linked FXI species with different electrophoretic mobilities in plasma, which collapsed into a single entity under reducing conditions. Recombinant expression reproduced this heterogeneity in dimeric and apparent monomeric species. Mutagenesis did not support Cys295-mediated interchain disulfide formation or involvement of Cys29 in the aberrant dimer. Proteomic analysis discarded interaction with other proteins and identified Carbamidomethylation (CAM)-modified Cys317, Cys321, and Cys193 exclusively in mutant FXI, indicating altered thiol availability. Contact pathway-dependent FIX activation in the proband was associated with impaired thrombin generation, whereas tissue factor-triggered thrombin generation was preserved. The proband had no spontaneous bleeding and underwent two procedures uneventfully with prophylaxis. Conclusion: The p.Phe295Cys variant is associated with disulfide-dependent structural heterogeneity and impaired FXI function. The findings support perturbation of the native FXI disulfide network but do not establish the precise alternative disulfide connectivity.

Thrombosis and Haemostasis
Centro Regional de Hemodonación (ES), Instituto Murciano de Investigación Biosanitaria (ES), Universidad de Murcia (ES)
Ministerio de Ciencia, Innovación y Universidades
Good health and well-being
Openalex Percentile: Top 13%
Coagulation, Bradykinin, Polyphosphates, and Angioedema
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon